Current studies show that EZH2/NXPH4/CDKN2A axis can participate in regulating the proliferation and migration of non-small-cell lung cancer cells [18] revealing a poor prognosis in the prognosis model of breast cancer [53]. This evidence concerns the gene EZH2 and non-small cell lung carcinoma.